IJ Pharmaceutical Research
Scopus by Title (Ref)
1. Drug Repurposing and Molecular Insights in the Fight Against Breast Cancer
- Jakhmola-Mani R. , et al.
2. Drugs repurposed: An advanced step towards the treatment of breast cancer and associated challenges
- Malik J.A. , et al.
3. A combined bioinformatic and nanoparticle-based study reveal the role of abcg2 in the drug resistant breast cancer
- Huo Q. , et al.
4. Pharmacodynamic mechanisms of anti-inflammatory drugs on the chemosensitization of multidrug-resistant cancers and the pharmacogenetics effectiveness
- Gholamian Dehkordi N. , et al.
5. Evaluation the interaction of ABC multidrug transporter MDR1 with thymoquinone: substrate or inhibitor?
- Keyvani V. , et al.
6. Drug-resistance in rheumatoid arthritis: the role of p53 gene mutations, ABC family transporters and personal factors
- Zhang K.X. , et al.
7. Crocin increases gastric cancer cells' sensitivity to doxorubicin
- Razavi S.M.S. , et al.
8. Inflammatory pathway interactions and cancer multidrug resistance regulation
- Mirzaei S.A. , et al.
9. Design of colloidal drug carriers of celecoxib for use in treatment of breast cancer and leukemia
- Üner M. , et al.
10. ABCG2 aptamer selectively delivers doxorubicin to drug-resistant breast cancer cells
- Hashemitabar S. , et al.
11. Expression of oncoprotein gankyrin in drug resistant and sensitive cancer ovarian and gastric cancer cell lines
- Taheri M. , et al.
12. Celecoxib in breast cancer prevention and therapy
- Li J. , et al.
13. Ionic liquid-assisted synthesis of celexocib using tris-(2-hydroxyethyl) ammonium acetate as an efficient and reusable catalyst
- Ahfad-Hosseini H.R. , et al.
14. Unexpected lower expression of oncoprotein Gankyrin in drug resistant ABCG2 overexpressing breast cancer cell lines
- Taheri M. , et al.
15. NSAIDs induced regulation of alternatively spliced transcript isoforms: Possible role in cancer and alzheimer disease
- Husain M.A. , et al.
16. Alterations in ACE and ABCG2 expression levels in the testes of rats subjected to atropine-induced toxicity
- Li X. , et al.
17. MiR 221/222 as new players in tamoxifen resistance
- Alamolhodaei N.S. , et al.
18. ABCG2 inhibition as a therapeutic approach for overcoming multidrug resistance in cancer
- Hasanabady M.H. , et al.